Changes in cortisol/Adrenocorticotropic levels at different stages of hormone therapy in children with primary nephrotic syndrome and the potential to predict recurrence

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900026102

Enrollment

Unknown

Registered

2019-09-21

Start date

2019-09-18

Completion date

Unknown

Last updated

2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary nephrotic syndrome

Interventions

The experimental group

The control group:no

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. meet the diagnostic criteria of primary nephrotic syndrome in children; 2. aged <=18 years old; 3. previous or recent 3 months did not apply hormones, immunosuppressive agents, blood purification treatment.

Exclusion criteria

Exclusion criteria: 1. Previous or recent 3 months of the application of hormones, immunosuppressive agents, blood purification treatment; 2. On account of economic difficulties or poor adherence, the patients cannot complete clinical observation; 3. With organic diseases (heart, liver, gastrointestinal, blood diseases, etc.).

Design outcomes

Primary

Measure	Time frame
Blood cortisol;Adrenocorticotropic hormone;	—

Countries

China

Contacts

Public ContactZhang Jianjiang

The First Affiliated Hospital of Zhengzhou University

zhangjianjiang10@163.com+86 15936269856

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026